Finance

Beta
Lists
NEULANDLAB:NSE
Neuland Laboratories Ltd
₹16,900.00
-0.54%
(-92.00) 1D
Jun 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NEULANDLAB...
Open
₹16,992.00
High
₹17,181.00
Low
₹16,710.00
Mkt. cap
216.83B
Avg. vol.
69.05K
Volume
30.57K
Dividend
0.20%
Quarterly dividend
₹8.50
Ex-dividend date
Jul 24, 2026
P/E ratio
59.57
52-wk high
₹19,747.00
52-wk low
₹11,500.00
EPS
₹283.71
Shares outstanding
12.83M
No. of employees
2K
Open
₹16,992.00
High
₹17,181.00
Low
₹16,710.00
Mkt. cap
216.83B
Avg. vol.
69.05K
Volume
30.57K
Dividend
0.20%
Quarterly dividend
₹8.50
Ex-dividend date
Jul 24, 2026
P/E ratio
59.57
52-wk high
₹19,747.00
52-wk low
₹11,500.00
EPS
₹283.71
Shares outstanding
12.83M
No. of employees
2K
News stories
From sources across the web
About Neuland Laboratories Ltd
CEO-
Employees2.19K
Founded1984
Headquarters-
SectorPharmaceutical industry
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹165.76 / ₹78.16
+112.08%beat
Revenue / Est. (INR)
7.76B / 5.43B
+42.93%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.93B
5.14B
4.40B
7.76B
Cost of goods sold
1.53B
2.30B
2.44B
3.21B
Cost of revenue
1.53B
2.30B
2.44B
3.21B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
734.65M
803.72M
888.32M
984.72M
Operating expense
1.26B
1.52B
1.43B
1.73B
Total operating expenses
2.78B
3.81B
3.86B
4.94B
Operating income
142.99M
1.33B
532.13M
2.82B
Other non operating income
78.56M
18.00M
80.52M
124.58M
EBT including unusual items
175.70M
1.29B
544.75M
2.87B
EBT excluding unusual items
175.70M
1.29B
544.75M
2.87B
Income tax expense
36.70M
325.83M
139.04M
748.22M
Effective tax rate
20.89%
25.17%
25.52%
26.03%
Other operating expenses
318.80M
487.90M
301.24M
494.35M
Net income
139.00M
968.54M
405.72M
2.13B
Net profit margin
4.75%
18.83%
9.23%
27.40%
Earnings per share
10.83
75.49
31.62
165.76
Interest and investment income
-
-
-
-
Interest expense
-45.85M
-53.67M
-67.90M
-72.05M
Net interest expenses
-45.85M
-53.67M
-67.90M
-72.05M
Depreciation and amortization charges
201.90M
225.42M
239.20M
250.89M
EBITDA
291.26M
1.54B
680.40M
3.05B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more